vs
Castellum, Inc.(CTM)与Spero Therapeutics, Inc.(SPRO)财务数据对比。点击上方公司名可切换其他公司
Spero Therapeutics, Inc.的季度营收约是Castellum, Inc.的1.0倍($12.6M vs $12.6M),Spero Therapeutics, Inc.净利率更高(250.7% vs -10.5%,领先261.2%),Spero Therapeutics, Inc.同比增速更快(24080.8% vs 21.9%),过去两年Spero Therapeutics, Inc.的营收复合增速更高(847.7% vs 5.3%)
Castellum, Inc.是一家总部位于美国的网络安全与信息技术服务提供商,服务覆盖国防政府机构、公共部门及商业企业客户,提供威胁检测、数据保护、云安全及托管IT解决方案,助力客户防范网络风险、保护核心数字资产。
CTM vs SPRO — 直观对比
营收规模更大
SPRO
是对方的1.0倍
$12.6M
营收增速更快
SPRO
高出24058.8%
21.9%
净利率更高
SPRO
高出261.2%
-10.5%
两年增速更快
SPRO
近两年复合增速
5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $12.6M | $12.6M |
| 净利润 | $-1.3M | $31.5M |
| 毛利率 | 33.9% | — |
| 营业利润率 | -11.1% | — |
| 净利率 | -10.5% | 250.7% |
| 营收同比 | 21.9% | 24080.8% |
| 净利润同比 | 51.8% | 250.9% |
| 每股收益(稀释后) | $-0.02 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTM
SPRO
| Q4 25 | $12.6M | $12.6M | ||
| Q3 25 | $14.6M | $0 | ||
| Q2 25 | $14.0M | $0 | ||
| Q1 25 | $11.7M | $12.0K | ||
| Q4 24 | $10.3M | $52.0K | ||
| Q3 24 | $11.6M | $65.0K | ||
| Q2 24 | $11.5M | $114.0K | ||
| Q1 24 | $11.3M | $140.0K |
净利润
CTM
SPRO
| Q4 25 | $-1.3M | $31.5M | ||
| Q3 25 | $415.4K | $-7.4M | ||
| Q2 25 | $-322.1K | $-1.7M | ||
| Q1 25 | $-1.2M | $-13.9M | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $-1.3M | $-17.1M | ||
| Q2 24 | $-1.8M | $-17.9M | ||
| Q1 24 | $-4.1M | $-12.7M |
毛利率
CTM
SPRO
| Q4 25 | 33.9% | — | ||
| Q3 25 | 37.6% | — | ||
| Q2 25 | 36.1% | — | ||
| Q1 25 | 39.0% | — | ||
| Q4 24 | 40.0% | — | ||
| Q3 24 | 42.7% | — | ||
| Q2 24 | 40.6% | — | ||
| Q1 24 | 39.8% | — |
营业利润率
CTM
SPRO
| Q4 25 | -11.1% | — | ||
| Q3 25 | 3.0% | — | ||
| Q2 25 | -2.7% | — | ||
| Q1 25 | -12.7% | -122758.3% | ||
| Q4 24 | -15.7% | — | ||
| Q3 24 | -11.9% | -28604.6% | ||
| Q2 24 | -13.6% | -16720.2% | ||
| Q1 24 | -23.6% | -9987.1% |
净利率
CTM
SPRO
| Q4 25 | -10.5% | 250.7% | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | -2.3% | — | ||
| Q1 25 | -10.0% | -115550.0% | ||
| Q4 24 | -26.6% | — | ||
| Q3 24 | -11.0% | -26380.0% | ||
| Q2 24 | -16.0% | -15668.4% | ||
| Q1 24 | -36.3% | -9049.3% |
每股收益(稀释后)
CTM
SPRO
| Q4 25 | $-0.02 | $0.56 | ||
| Q3 25 | $0.00 | $-0.13 | ||
| Q2 25 | $0.00 | $-0.03 | ||
| Q1 25 | $-0.01 | $-0.25 | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.02 | $-0.32 | ||
| Q2 24 | $-0.03 | $-0.33 | ||
| Q1 24 | $-0.08 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.8M | $59.0M |
| 总资产 | $41.9M | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CTM
SPRO
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
总债务
CTM
SPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $8.3M | — | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $9.0M | — |
股东权益
CTM
SPRO
| Q4 25 | $35.8M | $59.0M | ||
| Q3 25 | $36.7M | $26.5M | ||
| Q2 25 | $31.8M | $32.8M | ||
| Q1 25 | $26.1M | $33.8M | ||
| Q4 24 | $20.2M | $46.1M | ||
| Q3 24 | $12.0M | $65.5M | ||
| Q2 24 | $12.1M | $80.5M | ||
| Q1 24 | $12.8M | $96.2M |
总资产
CTM
SPRO
| Q4 25 | $41.9M | $68.9M | ||
| Q3 25 | $46.3M | $54.2M | ||
| Q2 25 | $43.4M | $62.1M | ||
| Q1 25 | $41.1M | $77.7M | ||
| Q4 24 | $37.8M | $110.5M | ||
| Q3 24 | $28.8M | $135.2M | ||
| Q2 24 | $29.5M | $149.9M | ||
| Q1 24 | $30.5M | $167.7M |
负债/权益比
CTM
SPRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.69× | — | ||
| Q2 24 | 0.72× | — | ||
| Q1 24 | 0.70× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-661.7K | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CTM
SPRO
| Q4 25 | $-661.7K | $-8.4M | ||
| Q3 25 | $1.0M | $17.4M | ||
| Q2 25 | $214.2K | $-17.7M | ||
| Q1 25 | $-2.5M | $-4.0M | ||
| Q4 24 | $-394.4K | $-23.4M | ||
| Q3 24 | $742.2K | $12.8M | ||
| Q2 24 | $748.6K | $-18.7M | ||
| Q1 24 | $23.7K | $5.9M |
自由现金流
CTM
SPRO
| Q4 25 | — | — | ||
| Q3 25 | $957.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $738.9K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率
CTM
SPRO
| Q4 25 | — | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度
CTM
SPRO
| Q4 25 | — | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率
CTM
SPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图